Geertruida H de Bock

Biographic Data

ID5912530
NAMEGeertruida H de Bock
GIVEN NAMESGeertruida H
FAMILY NAMEde Bock
SIGNATUREDE BOCK G H
AFFILIATIONSUniversity Medical Center Groningen
ORCID0000-0003-3104-4471
VERIFIEDYes
TOTAL WORKS13
TOTAL CITATIONS0
WORKS AS AUTHOR13
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2015
LATEST PUBLICATION YEAR2026
H-INDEX0

  • Improving participation in breast cancer screening through a tailored reminder letter

    Open AccessAllegra Ferrari, Mathieu Goossens et al.ARTICLEInternational Journal for Equity…2026

    Organized breast cancer (BC) screening facilitates early detection, improving treatment outcomes and reducing mortality. In Flanders, Belgium, participation in the Breast Cancer Screening Program is associated with substantial reductions in BC-specific mortality. However, participation remains suboptimal and socially patterned, with rates falling below 40% in areas with average income around the poverty line. In this trial, we evaluated whether a…

  • Efficient high-risk human papillomavirus screening through pooled testing

    Open AccessFengming Pan, Marcel JW Greuter et al.ARTICLEJournal of Global Health2026

    Background: The World Health Organization recommends high-risk human papillomavirus (hrHPV) testing as the primary method for cervical cancer screening. Combining samples in a pool can reduce the expense associated with large numbers of commercially available tests. This study simulated the potential test-saving impact of pooled hrHPV testing using real-world data from two low- and middle-income countries (LMICs). Methods: We simulated a two- and…

  • The effect of hrHPV prevalence on cervical cancer screening strategies

    Open AccessFengming Pan, Jurjen van der Schans et al.ARTICLEBMC Public Health2025

    Our study demonstrates that the hrHPV test + VIA strategy is cost-effective both compared to no screening and VIA + colposcopy screening strategy under the optimal (70%) and realistic (8.7%) uptake scenarios, with greater cost-effectiveness at higher hrHPV prevalence levels. While VIA-based strategy is cheaper, self-sampling hrHPV test-based strategy offers greater health benefits. Implementing hrHPV testing in national screening programs at lowe…

  • High-risk human papillomavirus testing for underscreened populations

    Open AccessMarat Sultanov, Geertruida H de Bock et al.ARTICLEBMC Public Health2025

    The provided estimates can serve to inform policymakers and researchers in the context of implementing hrHPV-based screening in diverse settings

  • Early evaluation of a screen-and-treat strategy using high-risk HPV testing for Uganda

    Open AccessMarat Sultanov, Jurjen van der Schans et al.ARTICLEJournal of Global Health2024

    Background: Uganda has a high burden of cervical cancer and its current coverage of screening based on visual inspection with acetic acid (VIA) is low. High-risk HPV (hrHPV) testing is recommended by the World Health Organization as part of the global elimination strategy for cervical cancer. In this context, country-specific health economic evaluations can inform national-level decisions regarding implementation. We evaluated the recommended hrH…

  • Impact of health-related behavioral factors on participation in a cervical cancer screening program

    Open AccessKelly Melisa Castañeda, Grigory Sidorenkov et al.ARTICLEBMC Public Health2023

    An association exists between unhealthy behavioral factors and never or irregular participation in cervical cancer screening

  • Investigating feasibility of 2021 WHO protocol for cervical cancer screening in underscreened populations

    Open AccessMarat Sultanov, Janine de Zeeuw et al.ARTICLEBMC Public Health2022

    ClinicalTrials.gov, NCT05234112 . Registered 10 February 2022

  • The Role of Socio-Demographic Factors in the Coverage of Breast Cancer Screening

    Open AccessLilu Ding, Svetlana Jidkova et al.ARTICLEFrontiers in Public Health2021

    Background: In Flanders, breast cancer (BC) screening is performed in a population-based breast cancer screening program (BCSP), as well as in an opportunistic setting. Women with different socio-demographic characteristics are not equally covered by BC screening. Objective: To evaluate the role of socio-demographic characteristics on the lowest 10th and highest 90th quantile levels of BC screening coverage. Methods: The 2017 neighborhood-level c…

  • Determinants of Population-Based Cancer Screening Performance at Primary Healthcare Institutions in China

    Open AccessSenshuang Zheng, Xiaorui Zhang et al.ARTICLEInternational Journal of…2021

    Primary healthcare institutions in China perform better in colorectal than in breast and cervical cancer screening, and institutions in rural districts perform better than institutions in urban districts. Increasing the number of staff members on breast and cervical cancer screening could improve the performance of population-based cancer screening

  • Informing policy makers on the efficiency of population level tobacco control interventions in Asia

    Open AccessAriuntuya Tuvdendorj, Yihui Du et al.ARTICLEJournal of Global Health2020

  • Coverage determinants of breast cancer screening in Flanders

    Open AccessLilu Ding, Svetlana Jidkova et al.ARTICLEInternational Journal for Equity…2020

    Coverage rate of BC screening is not optimal in Flanders. Women with low SES that are characterized by younger age, living in a high population density area, living in crowded households, or having low dental care are less likely to be screened for BC in Flanders. If screened, they are more likely to be screened outside the BCSP

  • Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation

    Open AccessMarcelo Cristiano de Azevedo Ramos, Maria Aparecida Azevedo Koike Folgueira et…ARTICLERevista de Saúde Pública2018

    OBJECTIVE: To analyze the cost effectiveness of the diagnostic program for the germline mutation in BRCA1/2 genes and of preventative strategies for the relatives of patients diagnosed with ovarian cancer associated with this mutation. METHODS: The study analyzed the cost effectiveness by developing an analysis of the Markov decision process from the perspective of the National Health System. The strategies compared reflect upon the adoption of g…

  • Patients' preferences for post‐treatment breast cancer follow‐up in primary care vs. secondary care

    Open AccessCarriene Roorda, Geertruida H de Bock et al.ARTICLEHealth Expectations2015

    OBJECTIVE: To explore patients' preferences for follow-up in primary care vs. secondary care. METHODS: A cross-sectional design was employed, involving semi-structured interviews with 70 female patients with a history of early-stage breast cancer. Using descriptive content analysis, interview transcripts were analysed independently and thematically by two researchers. FINDINGS: Patients expressed the strongest preference for annual visits (31/68)…